ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
하이엔드 셀로믹스 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 8.4%의 연평균 성장률로 43억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 세포 분석에서 AI와 머신러닝의 통합, 3D 세포배양 모델의 채택 확대, 자동화 및 고처리량 시스템에 대한 수요 증가, 재생의학 및 유전자 치료에 대한 관심 증가, 헬스케어 인프라가 개선되는 신흥 시장으로의 진출 등에 기인할 것으로 예상됩니다. 예측 기간 동안 주요 동향으로는 AI를 활용한 이미지 분석, 고함량 스크리닝과 CRISPR 기술의 통합, 3D 세포배양 및 오가노이드 모델 개발, 세포 기반 분석의 자동화 및 소형화, 클라우드 기반 데이터 관리 및 분석 플랫폼 등을 꼽을 수 있습니다.
정밀의료에 대한 수요 증가가 하이엔드 셀로믹스 시장 확대를 견인할 것으로 예상됩니다. 정밀의료는 유전적 체질, 생활습관, 환경 등에 따라 환자 개개인의 치료법을 맞춤화하는 치료 접근법입니다. 정밀의료의 급격한 증가는 유전체학의 발전에 힘입어 보다 효과적이고 부작용이 적은 맞춤형 치료가 가능해졌습니다. 하이엔드 셀로믹스는 첨단 이미징 기술을 통해 세포의 거동을 실시간으로 파악하여 바이오마커를 식별하고 질병 진행을 추적하는 데 도움을 줍니다. 이를 통해 맞춤형 치료 계획을 정교화하고 진단 정확도를 높여 정밀 의료를 개선할 수 있습니다. 예를 들어, 2024년 2월, 미국에 본사를 둔 헬스케어 단체인 개인화된 의학 연합(Personalized Medicine Coalition)은 2023년 FDA가 승인한 희귀 질환에 대한 개인화된 치료제는 16종으로 2022년 6종에 불과했던 것에 비해 증가했다고 보고했습니다. 그 결과, 정밀의료에 대한 수요 증가가 하이엔드 셀로믹스 시장의 성장을 견인하고 있습니다.
하이엔드 셀로믹스 시장의 기업들은 상세한 표현형 분석으로 정밀의료와 신약개발을 지원하는 고함량 분석 시스템 등의 제품 발전에 집중하고 있습니다. 고함량 분석(HCA) 시스템은 고처리량 환경에서 여러 세포 파라미터를 동시에 측정할 수 있는 첨단 이미징 툴입니다. 복잡한 생물학적 과정을 세포 수준에서 분석할 수 있어 신약개발, 독성 시험, 맞춤의료에 귀중한 데이터를 제공합니다. 예를 들어, 2024년 2월, 전기공학 및 소프트웨어 전문 기업인 일본의 요코가와 전기 주식회사는 CellVoyager CQ3000을 출시하였습니다. 이 벤치탑형 고함량 분석 시스템은 생세포배양의 고화질 3D 이미지를 신속하게 획득하여 세포 반응과 약효를 상세하고 효율적으로 평가할 수 있습니다. 광독성을 최소화하는 듀얼 스피닝 디스크 기술을 채택한 요꼬가와전기 독자적인 공초점 스캐너 유닛, 안정적이고 장시간의 라이브 셀 이미징을 가능하게 하는 고정밀 온도 제어, 딥러닝 분석용 옵션 등을 탑재하고 있습니다. 이미지 분석 소프트웨어 CellPathfinder와 결합하여 고도의 데이터 분석이 가능하여, 신약개발 연구, 재생의료 연구, 기초생물학 연구를 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 하이엔드 셀로믹스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 하이엔드 셀로믹스 시장 : 성장률 분석
세계의 하이엔드 셀로믹스 시장 실적 : 규모와 성장, 2019-2024년
세계의 하이엔드 셀로믹스 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 하이엔드 셀로믹스 전체 시장(TAM)
제6장 시장 세분화
세계의 하이엔드 셀로믹스 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
기기
시약 및 소모품
소프트웨어와 서비스
세계의 하이엔드 셀로믹스 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
현미경 검사
유세포 분석
단일세포 게노믹스
질량 분석
차세대 시퀀싱
기타 기술
세계의 하이엔드 셀로믹스 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Drug Discovery
암 조사
신경과학
줄기세포 조사와 재생의료
맞춤형 의료
기타 용도
세계의 하이엔드 셀로믹스 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
바이오테크놀러지 및 제약회사
병원 및 진단 검사실
계약 연구기관
기타 최종사용자
세계의 하이엔드 셀로믹스 시장, 기기 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
HCS(High Content Screening) 시스템
유세포 분석기
공초점 현미경
자동 현미경 시스템
이미지 분석 워크스테이션
로봇 세포 처리 시스템
세계의 하이엔드 셀로믹스 시장, 시약 및 소모품 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
형광 색소와 프로브
세포 염색 키트
세포배양 시약
어세이 키트
마이크로플레이트
슬라이드와 커버 글래스
고정액과 완충액
세계의 하이엔드 셀로믹스 시장, 소프트웨어와 서비스 하위 세분화(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
이미지 분석 소프트웨어
데이터 관리 및 통합 툴
인공지능(AI) 기반 예측 분석 소프트웨어
클라우드 기반 데이터 스토리지 솔루션
기술 지원 및 유지보수 서비스
커스텀 어세이 개발 서비스
트레이닝 및 사용자 서포트 프로그램
제7장 지역별·국가별 분석
세계의 하이엔드 셀로믹스 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 하이엔드 셀로믹스 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
하이엔드 셀로믹스 시장 : 경쟁 구도
하이엔드 셀로믹스 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Becton, Dickinson and Company(BD) Overview, Products and Services, Strategy and Financial Analysis
GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Sartorius AG
Bio-Rad Laboratories
Yokogawa Electric Corporation
Bruker Corporation
Carl Zeiss AG
Miltenyi Biotec GmbH
Leica Microsystems GmbH
10x Genomics
Promega Corporation
Abcam plc
Molecular Devices LLC
NanoString Technologies
Sphere Fluidics
Nikon Instruments Inc.
Tecan Group Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
하이엔드 셀로믹스 시장 2029년 : 새로운 기회를 제공하는 국가
하이엔드 셀로믹스 시장 2029년 : 새로운 기회를 제공하는 부문
하이엔드 셀로믹스 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
High-end cellomics involves state-of-the-art, automated technologies that combine high-content imaging with advanced data analytics to study cellular behavior at the single-cell level. These platforms facilitate high-throughput screening and deliver quantitative insights into cell morphology, molecular expression, and functional responses. They are particularly effective for identifying subtle cellular changes in response to drugs or environmental factors.
The primary product types in high-end cellomics include instruments, reagents and consumables, and software and services. Instruments are sophisticated scientific tools designed for precise measurement, imaging, and analysis of cells, tissues, and biological samples in both research and clinical applications. These tools incorporate various technologies such as microscopy, flow cytometry, single-cell genomics, mass spectrometry, next-generation sequencing, and more, serving a range of applications such as drug discovery, cancer research, neuroscience, stem cell research, regenerative medicine, personalized medicine, and others. They are utilized by diverse end-users, including biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, and more.
The high end cellomics market research report is one of a series of new reports from The Business Research Company that provides high end cellomics market statistics, including the high end cellomics industry global market size, regional shares, competitors with the high end cellomics market share, detailed high end cellomics market segments, market trends, opportunities, and any further data you may need to thrive in the high end cellomics industry. This high end cellomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The high-end cellomics market size has grown strongly in recent years. It will grow from $2.90 billion in 2024 to $3.15 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth during the historic period can be attributed to the increasing demand for high-content screening in drug discovery, technological advancements in imaging systems, growth in personalized medicine research, rising investments in academic and pharmaceutical research and development, and the expansion of stem cell and cancer research applications.
The high-end cellomics market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period is expected to result from the integration of AI and machine learning in cell analysis, the growing adoption of 3D cell culture models, the rising demand for automated and high-throughput systems, the increasing focus on regenerative medicine and gene therapy, and the expansion into emerging markets with improving healthcare infrastructure. Major trends during the forecast period include AI-driven image analysis, the integration of high-content screening with CRISPR technologies, the development of 3D cell culture and organoid models, automation and miniaturization of cell-based assays, and cloud-based data management and analytics platforms.
The growing demand for precision medicine is expected to drive the expansion of the high-end cellomics market. Precision medicine is an approach to treatment that customizes therapies for individual patients based on their genetic makeup, lifestyle, and environment. The surge in precision medicine is fueled by advancements in genomics, allowing for personalized treatments that are more effective and have fewer side effects. High-end cellomics uses advanced imaging technologies to provide real-time insights into cellular behavior, helping identify biomarkers and track disease progression. This improves precision medicine by refining personalized treatment plans and enhancing diagnostic accuracy. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from just six in 2022. As a result, the rising demand for precision medicine is driving growth in the high-end cellomics market.
Companies in the high-end cellomics market are focused on advancing products such as high-content analysis systems to support precision medicine and drug discovery with detailed phenotypic analysis. A high-content analysis (HCA) system is an advanced imaging tool that can simultaneously measure multiple cellular parameters in high-throughput environments. It allows for the analysis of complex biological processes at the cellular level, providing valuable data for drug discovery, toxicity testing, and personalized medicine. For example, in February 2024, Yokogawa Electric Corporation, a Japan-based company specializing in electrical engineering and software, launched the CellVoyager CQ3000. This benchtop high-content analysis system captures high-definition 3D images of live cell cultures quickly, allowing for detailed and efficient evaluation of cellular reactions and drug effects. It features Yokogawa's proprietary confocal scanner unit with dual spinning-disk technology to minimize phototoxicity, high-precision temperature control for stable long-term live cell imaging, and options for deep learning analysis. When combined with the CellPathfinder image analysis software, it facilitates advanced data analysis, supporting drug discovery, regenerative medicine research, and basic biological studies.
In January 2023, Bruker Corporation, a U.S.-based provider of advanced fluorescence microscopy imaging products, acquired ACQUIFER Imaging GmbH for an undisclosed sum. This acquisition strengthens Bruker's bioimaging portfolio by integrating ACQUIFER's flagship HIVE data management systems, which offer high-performance computing, deep learning, and scalable data storage solutions. ACQUIFER Imaging GmbH, based in Germany, specializes in big-data management solutions for bioimaging and high-content microscopy.
Major players in the high end cellomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company (BD), GE Healthcare, Agilent Technologies Inc., Sartorius AG, Bio-Rad Laboratories, Yokogawa Electric Corporation, Bruker Corporation, Carl Zeiss AG, Miltenyi Biotec GmbH, Leica Microsystems GmbH, 10x Genomics, Promega Corporation, Abcam plc, Molecular Devices LLC, NanoString Technologies, Sphere Fluidics, Nikon Instruments Inc., and Tecan Group Ltd.
North America was the largest region in the high-end cellomics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in high-end cellomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the high-end cellomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The high-end cellomics market consists of revenues earned by entities by providing services such as single-cell analysis, target identification and validation, and customization. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-end cellomics market also includes sales of assay kits, cell imaging plates, live-cell imaging chambers, and artificial intelligence (AI)-based analytics modules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified.)
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
High End Cellomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on high end cellomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for high end cellomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The high end cellomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
2) By Technology: Microscopy; Flow Cytometry; Single-Cell Genomics; Mass Spectrometry; Next Generation Sequencing; Other Technologies
3) By Application: Drug Discovery; Cancer Research; Neuroscience; Stem Cell Research And Regenerative Medicine; Personalized Medicine; Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostic Laboratories; Contract Research Organizations; Other End-Users
Subsegments:
1) By Instruments: High-Content Screening Systems; Flow Cytometers; Confocal Microscopes; Automated Microscopy Systems; Image Analysis Workstations; Robotic Cell Handling Systems
2) By Reagents And Consumables: Fluorescent Dyes And Probes; Cell Staining Kits; Cell Culture Reagents; Assay Kits; Microplates; Slide And Cover Glasses; Fixatives And Buffers
3) By Software And Services: Image Analysis Software; Data Management And Integration Tools; Artificial Intelligence (AI)-Based Predictive Analytics Software; Cloud-Based Data Storage Solutions; Technical Support And Maintenance Services; Custom Assay Development Services; Training And User Support Programs
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company (BD); GE Healthcare; Agilent Technologies Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. High End Cellomics Market Characteristics
3. High End Cellomics Market Trends And Strategies
4. High End Cellomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global High End Cellomics Growth Analysis And Strategic Analysis Framework
5.1. Global High End Cellomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global High End Cellomics Market Growth Rate Analysis
5.4. Global High End Cellomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global High End Cellomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global High End Cellomics Total Addressable Market (TAM)
6. High End Cellomics Market Segmentation
6.1. Global High End Cellomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents And Consumables
Software And Services
6.2. Global High End Cellomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microscopy
Flow Cytometry
Single-Cell Genomics
Mass Spectrometry
Next Generation Sequencing
Other Technologies
6.3. Global High End Cellomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery
Cancer Research
Neuroscience
Stem Cell Research And Regenerative Medicine
Personalized Medicine
Other Applications
6.4. Global High End Cellomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biotechnology And Pharmaceutical Companies
Hospitals And Diagnostic Laboratories
Contract Research Organizations
Other End-Users
6.5. Global High End Cellomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High-Content Screening Systems
Flow Cytometers
Confocal Microscopes
Automated Microscopy Systems
Image Analysis Workstations
Robotic Cell Handling Systems
6.6. Global High End Cellomics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluorescent Dyes And Probes
Cell Staining Kits
Cell Culture Reagents
Assay Kits
Microplates
Slide And Cover Glasses
Fixatives And Buffers
6.7. Global High End Cellomics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
